Influenza – (IIV3, ccIIV3)
Recommended Age Range:
Annually for children 6 months and older
Common Side Effects:
Injection site pain, low-grade fever, aches
Research & Testing History:
Annual since 2004 for children
Use History:
In use since 1955
Trial Size:
Trials vary yearly; extensive data
Years on Schedule:
~21 year
Known Safety Concerns:
Rare allergic reactions
Ingredients:
- Afluria: Sodium chloride, monobasic sodium phosphate, dibasic sodium phosphate, monobasic potassium phosphate, potassium chloride, calcium chloride, thimerosal (multi-dose vials only), residuals: sodium taurodeoxycholate, ovalbumin, sucrose, neomycin sulfate, polymyxin B, beta-propiolactone, hydrocortisone
- FluLaval: Phosphate buffered saline, residuals: ovalbumin, formaldehyde, sodium deoxycholate, α-tocopheryl hydrogen succinate, polysorbate 80
- Fluad: MF59 adjuvant (squalene, polysorbate 80, sorbitan trioleate, sodium citrate dihydrate, citric acid monohydrate), residuals: neomycin, kanamycin, hydrocortisone, ovalbumin, formaldehyde, cetyltrimethylammonium bromide
- Fluarix: Triton X-100, α-tocopheryl hydrogen succinate, polysorbate 80, residuals: hydrocortisone, gentamicin sulfate, ovalbumin, formaldehyde, sodium deoxycholate
- Fluzone: Phosphate buffered saline, thimerosal (multi-dose vials only), residuals: Triton X-100, formaldehyde, ovalbumin